Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Medexus Pharma

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Chicago, Illinois, United States Founded 2012 101-250 employees For Profit

Medexus Pharma is a rare disease pharmaceutical company focusing on therapeutic areas of rheumatology and auto-immune conditions.

Medexus Pharma on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Total Funding
$172.84M
Funding Rounds
6
Last Funding
Acquisitions
2
Monthly Visits
Contacts
55
Ticker
MDP
TSX - Toronto Stock Exchange
Patents
0
1 trademarks

About Medexus Pharma

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
MDP
Exchange
TSX - Toronto Stock Exchange
IPO date
Mar 7, 2012

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
30
Active products
4
Patents granted
0
Trademarks
1
IT spend
$438.1K

Company Info

Founded
2012
Employees
101-250
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
Sub-organizations
1
News articles
73
HQ
Chicago, Illinois, United States
Region
Greater Chicago Area, Great Lakes, Midwestern US
Exit date
Mar 7, 2012

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
0.7
Trend (90d)
0

Medexus Pharma Funding Rounds

6 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesInvestor NamesFunding StageOrg IndustriesOrg Hq CityOrg Hq CountryOrg DescriptionOrg Number Of EmployeesOrg Website
1–5 of 6Show
Page 1 / 2

Medexus Pharma Acquisitions

2 results
Acquiree NameAcquirer NameAcquisition TypeAcquisition TermsAcquiree IndustriesAcquiree Hq CityAcquiree Hq CountryAcquiree DescriptionAcquiree Number Of EmployeesAcquirer IndustriesAcquirer Hq CountryAcquirer Number Of EmployeesAcquirer Ipo StatusAcquiree Website
Aptevo Therapeutics2020-02-28Medexus PharmaAcquisitionBiometricsBiopharmaBiotechnologyOncologySeattleUnited StatesAptevo Therapeutics is a biotech company primarily focused oBiotechnologyMedicalMedical DevicePharmaceuticalUnited States101-250Public2www.aptevotherapeutics.com/
Medac Pharma$50M2018-09-06Medexus PharmaMergerCash & StockMedicalPharmaceuticalTherapeuticsStirlingUnited KingdomMedac Pharma specializes in the development and treatment of1970-01-0111-50BiotechnologyMedicalMedical DevicePharmaceuticalUnited States101-250Public2medacpharma.co.uk/
1–2 of 2Show
Page 1 / 1
55
professional contacts at Medexus Pharma
Contact execs at Medexus Pharma

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Medexus Pharma

Loading news…

FAQs about Medexus Pharma

People who checked this page also checked these

Sectors Medexus Pharma invests & acquires in

M&A by year

Browse the full Acquirezy directory.